<i>MED12</i> mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways
Marick Laé(Institut Curie), Ivan Bièche(Délégation Paris 5)
Cited by 34
Related Papers
Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers
|Journal of Hematology & Oncology|2020|54
Clinical value of R-spondins in triple-negative and metaplastic breast cancers
|British Journal of Cancer|2017|39